Metabolic Effects of Sleep Extension in People with Obesity
Metabolic Effects of Sleep Extension in People with Obesity
批准号:
10201581
负责人:
Samuel Klein
金额:
$60.77万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2023-06-30
关键词:
Adipose tissueAdmission activityBedsBindingBiologyBiopsyBlood GlucoseBlood specimenBody WeightBody mass indexCaliforniaCardiometabolic DiseaseChronicCircadian DysregulationCircadian RhythmsCircadian desynchronyCollectionColoradoComplexDataEnergy IntakeEnsureEpidemiologyEventFatty acid glycerol estersFutureGene ExpressionGenesGlucoseGlucose ClampGlucose IntoleranceGlutathioneGlutathione DisulfideGoalsHealthHomeHormonesHourImpaired fasting glycaemiaInflammationInfusion proceduresInpatientsInsulinInsulin ResistanceInterventionIntervention StudiesInvestigationLinkLipolysisLiverMagnetic Resonance ImagingMass Spectrum AnalysisMeasurementMelatoninMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolismMolecularMuscleNarcolepsyNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsObesityOutcomeOxidative StressParticipantPeripheralPeripheral Blood Mononuclear CellPhysiologicalPlasmaPolysomnographyPrediabetes syndromeProceduresProstaglandinsProteinsRandomizedRandomized Controlled TrialsResearchResearch PersonnelResistance developmentRiskScheduleScienceSleepSleep Apnea SyndromesSleep DeprivationSleep DisordersSleeplessnessTestingTherapeuticTherapeutic EffectTimeTracerTriglyceridesUniversitiesUrineWashingtonWristactigraphyadult obesityattentional controlcircadiancircadian pacemakerclinically significantcytokineglucose disposalglucose productionhigh riskimprovedin vivoinflammatory markerinsightinsulin sensitivityinterdisciplinary collaborationintrahepaticmedical schoolsmetabolomemetabolomicsnovelsleep patternstable isotopesuprachiasmatic nucleusurinary
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Data from both epidemiological and sleep intervention studies have shown that insufficient sleep
causes metabolic dysfunction and is associated with an increased risk of developing obesity
and metabolic diseases, such as type 2 diabetes (T2D). However, a comprehensive
assessment of the potential therapeutic benefits of sleep extension have not been evaluated in
people. The overall goal of this proposal is to determine the effect of sleep extension on multi-
system metabolic function and the potential mechanisms responsible for the link between
insufficient sleep and metabolic dysfunction, including circadian misalignment, increased
oxidative stress, plasma metabolomics and both systemic and adipose tissue inflammation in
people with metabolically unhealthy obesity (MUO) who habitually maintain chronic short sleep
schedules. Accordingly, we have assembled a transdisciplinary research team with expertise in
metabolism (S. Klein, G. Smith at Washington University School of Medicine [WUSM]), sleep (K.
Wright, J. Broussard at University of Colorado Boulder and B. Lucey [WUSM]), circadian biology
and molecular science (J. Yoshino [WUSM]), and metabolomics (M. Jain at University of
California San Diego) to conduct a randomized controlled trial to assess a 6-wk sleep extension
intervention in people with MUO, who habitually sleep ≤6.0 h/night. We will determine the effect
of sleep extension, on: 1) multi-organ insulin sensitivity (assessed by using the two-stage
hyperinsulinemic-euglycemic clamp procedure in conjunction with stable isotope tracers), 2) 24h
plasma glucose, free fatty acids and hormone profiles, and 3) intrahepatic triglyceride content
(assessed by using magnetic resonance imaging) and the potential cellular mechanisms
responsible for insufficient sleep-induced metabolic dysfunction, by targeted (circadian
misalignment, clock genes, inflammation, and oxidative stress) and non-targeted (mass
spectroscopy-driven metabolome) approaches. The results from this transdisciplinary
collaboration will provide important insights into understanding the physiological and molecular
interactions between sleep and metabolic function, and could provide evidence for sleep
extension as a countermeasure to improve metabolic health in people at high risk for developing
metabolic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exosomes and insulin action in metabolically healthy and unhealthy obesity
-
批准号:10721302
-
项目类别:
-
资助金额:$57.38万
-
财政年份:2023
-
负责人:Samuel Klein
-
依托单位:
Washington University Nutrition Obesity Research Center
-
批准号:10160292
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2020
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:9765814
-
项目类别:
-
资助金额:$55.25万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10576314
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10338113
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:10089440
-
项目类别:
-
资助金额:$56.8万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Animal and plant proteins and glucose metabolism
-
批准号:9904616
-
项目类别:
-
资助金额:$56.76万
-
财政年份:2019
-
负责人:Samuel Klein
-
依托单位:
Metabolic Effects of Sleep Extension in People with Obesity
-
批准号:10435463
-
项目类别:
-
资助金额:$60.77万
-
财政年份:2018
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10316981
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10543046
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10713355
-
项目类别:
-
资助金额:$9.04万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
-
批准号:10224813
-
项目类别:
-
资助金额:$99.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10559326
-
项目类别:
-
资助金额:$3.03万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:10777442
-
项目类别:
-
资助金额:$1.94万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
NAD+ and metabolic flexibility
-
批准号:9978503
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of the glucagon receptor blocker REMD-477 on insulin requirements in type 1 diabetes
-
批准号:9041432
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
Assessment of Multiple Dose Administration ofGlucagon Receptor Blocker REMD477 in Type 1 Diabetes
-
批准号:10018859
-
项目类别:
-
资助金额:$99.38万
-
财政年份:2016
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:8671289
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:9306061
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位:
WEIGHT LOSS-INDEPENDENT METABOLIC EFFECTS OF ROUX-EN-Y GASTRIC BYPASS IN DIABETES
-
批准号:8928175
-
项目类别:
-
资助金额:$48.73万
-
财政年份:2014
-
负责人:Samuel Klein
-
依托单位: